Deep Repetitive Transcranial Magnetic Stimulation in the Treatment of Tinnitus
Key facts
- Who runs it
- University of Regensburg
- Where
- Germany1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 60 people, planned
- Started
- 19 Sept 2026
- Expected to end
- 31 Aug 2029
- Type of study
- Interventional, 3 groupsOne group gets a sham (pretend) treatment, for comparison.
- Treatments tested
- DeepTms
- Record updated
- 21 October 2026
Who can take part
- Age
- 18 years to 75 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (8)Hide the full registry criteria
Who can take part
- Chronic tinnitus (> 6 months)
- Moderate tinnitus burden-corresponding to a score of ≥ 18 on the Tinnitus Handicap Inventory
- Stable medication regimen with psychoactive substances
Who cannot take part
- Presence of contraindications for TMS (electrical implants or metallic objects in the body, such as a pacemaker or insulin pump)
- Severe and unstable internal medicine, neurological, and psychiatric comorbidities (particularly acute psychosis, severe depression, or substance dependence; epilepsy; brain tumor; encephalitis; history of traumatic brain injury)
- Meniere's disease, otosclerosis, acoustic neuroma, or other clear-cut or treatment-requiring causes of tinnitus
- Objective tinnitus
- Currently undergoing or planning to undergo tinnitus treatment during the study
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
- Tinnitus
This trial is currently available in Germany.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Study of the efficacy of different H-coils in chronic tinnitus. Hypothesis: Active Deep repetitive transcranial magnetic stimulation deeprTMS reduces tinnitus distress more effectively than placebo stimulation.
Read full original descriptionShow less
Randomized, placebo-controlled, parallel-group study with three treatment arms; additional comparison with a historical rTMS control group.
The 3 groups in the trial
- H1-coilTreatment being tested
18 Hz, 2000 pulses
Treatment: DeepTms
- H4-coilTreatment being tested
1 Hz, 2000 pulses
Treatment: DeepTms
- H7-coilSham treatment, for comparison
18 Hz, 2000 pulses placebo
Treatment: DeepTms
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Criteria questions
- Built from NCT07885176, who can take part
- Record updated
- 21 October 2026